Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.48M Sell
17,838
-953
-5% -$198K 0.04% 372
2026
Q1
$4.22M Buy
18,791
+2,515
+15% +$627K 0.07% 299
2025
Q4
$3.92M Sell
16,276
-1,460
-8% -$373K 0.06% 312
2025
Q3
$4.85M Buy
17,736
+8,784
+98% +$2.4M 0.08% 247
2025
Q2
$2.28M Sell
8,952
-587
-6% -$140K 0.04% 397
2025
Q1
$2.12M Sell
9,539
-10,151
-52% -$2.37M 0.04% 403
2024
Q4
$4.5M Buy
19,690
+1,562
+9% +$376K 0.09% 222
2024
Q3
$3.59M Sell
18,128
-1,113
-6% -$249K 0.09% 251
2024
Q2
$3.68M Buy
19,241
+1,113
+6% +$226K 0.09% 252
2024
Q1
$3.59M Buy
18,128
+1,906
+12% +$349K 0.09% 251
2023
Q4
$2.79M Buy
16,222
+3,523
+28% +$541K 0.08% 288
2023
Q3
$1.88M Buy
12,699
+5,678
+81% +$1.03M 0.07% 334
2023
Q2
$1.53M Sell
7,021
-171
-2% -$38.1K 0.06% 358
2023
Q1
$1.58M Buy
7,192
+306
+4% +$66.4K 0.06% 341
2022
Q4
$1.43M Sell
6,886
-3,016
-30% -$663K 0.08% 301
2022
Q3
$2.16M Buy
9,902
+1,008
+11% +$229K 0.15% 171
2022
Q2
$1.86M Buy
8,894
+1,018
+13% +$217K 0.13% 209
2022
Q1
$1.91M Buy
7,876
+2,289
+41% +$554K 0.13% 204
2021
Q4
$1.46M Buy
5,587
+634
+13% +$165K 0.11% 212
2021
Q3
$1.3M Buy
4,953
+222
+5% +$60.7K 0.13% 187
2021
Q2
$1.17M Buy
4,731
+1,179
+33% +$248K 0.14% 179
2021
Q1
$689K Buy
3,552
+669
+23% +$134K 0.12% 211
2020
Q4
$613K Buy
2,883
+852
+42% +$170K 0.16% 160
2020
Q3
$348K Buy
2,031
+57
+3% +$10.5K 0.13% 197
2020
Q2
$379K Sell
1,974
-356
-15% -$58.2K 0.22% 131
2020
Q1
$343K Buy
2,330
+111
+5% +$17.7K 0.29% 119
2019
Q4
$344K Buy
+2,219
New +$320K 0.25% 133

Other funds holding RMD

Ethic Inc's RMD Position: Q2 2026 in Review

Ethic Inc reduced its ResMed (RMD) stake by 5.1% in Q2 2026, selling an estimated $198K and leaving 17,838 shares worth $3.48M. The position accounts for 0.04% of the portfolio, ranked #372.

Ethic Inc first reported a position in RMD in Q4 2019 and has held it in 27 quarters since. The position peaked at $4.85M in Q3 2025. 279 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Ethic Inc held 17,838 shares of ResMed worth $3.48M as of Q2 2026.
  • Ethic Inc sold 953 ResMed shares in Q2 2026, an estimated $198K.
  • ResMed made up 0.04% of Ethic Inc's portfolio in Q2 2026, its #372 holding.
  • Ethic Inc first reported a position in ResMed in Q4 2019 and has held it in 27 quarters since.
  • Ethic Inc's ResMed position peaked at $4.85M in Q3 2025.
  • 279 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Ethic Inc's 13F filing for Q2 2026, filed 29 Jul 2026.